SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide
pandemic, and there is a pressing need to understand the development, specificity, and …

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
highlights the importance of determining the breadth and durability of humoral immunity to …

Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we
evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based …

The emergence of SARS-CoV-2 variants with mutations in the spike protein is raising concerns
about the efficacy of infection- or vaccine-induced antibodies. We compared antibody …

Purpose We investigated SARS-CoV-2 mRNA vaccine-induced binding and live-virus
neutralizing antibody response in NSCLC patients to the SARS-CoV-2 wild type strain and the …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant emerged
in November 2021 and consists of several mutations within the spike. We use serum from …

OBJECTIVES: We aimed to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
serological responses in children hospitalized with multisystem inflammatory …

Low plasma arginine bioavailability has been implicated in endothelial dysfunction and
immune dysregulation. The role of arginine in COVID-19 is unknown, but could contribute to …

SARS‐CoV‐2 is a recently emerged human coronavirus that has escalated to a pandemic.
There are currently no approved vaccines for SARS‐CoV‐2, which causes severe respiratory …

In this study, by characterizing several human monoclonal antibodies (mAbs) isolated from
single B cells of the COVID-19–recovered individuals in India who experienced ancestral …